1
|
Saller KM, Pernusch DC, Schwarzinger C. MALINTO: A New MALDI Interpretation Tool for Enhanced Peak Assignment and Semiquantitative Studies of Complex Synthetic Polymers. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2023; 34:293-303. [PMID: 36599090 PMCID: PMC9896554 DOI: 10.1021/jasms.2c00311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 12/15/2022] [Accepted: 12/16/2022] [Indexed: 06/17/2023]
Abstract
The newly developed MALDI interpretation tool ("MALINTO") allows for the accelerated characterization of complex synthetic polymers via MALDI mass spectrometry. While existing software provides solutions for simple polymers like poly(ethylene glycol), polystyrene, etc., they are limited in their application on polycondensates synthesized from two different kinds of monomers (e.g., diacid and diol in polyesters). In addition to such A2 + B2 polycondensates, MALINTO covers branched and even multicyclic polymer systems. Since the MALINTO software works based on input data of monomers/repeating units, end groups, and adducts, it can be applied on polymers whose components are previously known or elucidated. Using these input data, a list with theoretically possible polymer compositions and resulting m/z values is calculated, which is further compared to experimental mass spectrometry data. For optional semiquantitative studies, peak areas are allocated according to their assigned polymer composition to evaluate both comonomer and terminating group ratios. Several tools are implemented to avoid mistakes, for example, during peak assignment. In the present publication, the functions of MALINTO are described in detail and its broad applicability on different linear polymers as well as branched and multicyclic polycondensates is demonstrated. Fellow researchers will benefit from the accelerated peak assignment using the freely available MALINTO software and might be encouraged to explore the potential of MALDI mass spectrometry for (semi)quantitative applications.
Collapse
Affiliation(s)
- Klara M. Saller
- Institute
for Chemical Technology of Organic Materials, Johannes Kepler University Linz, Altenbergerstrasse 69, 4040Linz, Austria
| | - Daniel C. Pernusch
- Institute
for Chemical Technology of Organic Materials, Johannes Kepler University Linz, Altenbergerstrasse 69, 4040Linz, Austria
| | - Clemens Schwarzinger
- Institute
for Chemical Technology of Organic Materials, Johannes Kepler University Linz, Altenbergerstrasse 69, 4040Linz, Austria
| |
Collapse
|
2
|
YANG F, GUO H, ZHANG L, SHI J, SHEN M, HAN D, LI L. Identification of Confusable Herbal Medicines by Mapping of Partial Degradation Products from Herbal Medicine Polysaccharides. ANAL SCI 2018; 34:1291-1296. [DOI: 10.2116/analsci.18p058] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
| | | | | | - Jing SHI
- Department of Pharmacy, Hebei University
| | | | | | | |
Collapse
|
3
|
Harvey DJ. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012. MASS SPECTROMETRY REVIEWS 2017; 36:255-422. [PMID: 26270629 DOI: 10.1002/mas.21471] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2014] [Accepted: 01/15/2015] [Indexed: 06/04/2023]
Abstract
This review is the seventh update of the original article published in 1999 on the application of MALDI mass spectrometry to the analysis of carbohydrates and glycoconjugates and brings coverage of the literature to the end of 2012. General aspects such as theory of the MALDI process, matrices, derivatization, MALDI imaging, and fragmentation are covered in the first part of the review and applications to various structural types constitute the remainder. The main groups of compound are oligo- and poly-saccharides, glycoproteins, glycolipids, glycosides, and biopharmaceuticals. Much of this material is presented in tabular form. Also discussed are medical and industrial applications of the technique, studies of enzyme reactions, and applications to chemical synthesis. © 2015 Wiley Periodicals, Inc. Mass Spec Rev 36:255-422, 2017.
Collapse
Affiliation(s)
- David J Harvey
- Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, OX1 3QU, UK
| |
Collapse
|
4
|
Hinsch A, Buchholz M, Odinga S, Borkowski C, Koop C, Izbicki JR, Wurlitzer M, Krech T, Wilczak W, Steurer S, Jacobsen F, Burandt EC, Stahl P, Simon R, Sauter G, Schlüter H. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays. JOURNAL OF MASS SPECTROMETRY : JMS 2017; 52:165-173. [PMID: 28117928 DOI: 10.1002/jms.3916] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2016] [Revised: 01/13/2017] [Accepted: 01/19/2017] [Indexed: 06/06/2023]
Abstract
For identification of clinically relevant masses to predict status, grade, relapse and prognosis of colorectal cancer, we applied Matrix-assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS) to a tissue micro array containing formalin-fixed and paraffin-embedded tissue samples from 349 patients. Analysis of our MALDI-IMS data revealed 27 different m/z signals associated with epithelial structures. Comparison of these signals showed significant association with status, grade and Ki-67 labeling index. Fifteen out of 27 IMS signals revealed a significant association with survival. For seven signals (m/z 654, 776, 788, 904, 944, 975 and 1013) the absence and for eight signals (m/z 643, 678, 836, 886, 898, 1095, 1459 and 1477) the presence were associated with decreased life expectancy, including five masses (m/z 788, 836, 904, 944 and 1013) that provided prognostic information independently from the established prognosticators pT and pN. Combination of these five masses resulted in a three-step classifier that provided prognostic information superior to univariate analysis. In addition, a total of 19 masses were associated with tumor stage, grade, metastasis and cell proliferation. Our data demonstrate the suitability of combining IMS and large-scale tissue micro arrays to simultaneously identify and validate clinically useful molecular marker. Copyright © 2017 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- A Hinsch
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - M Buchholz
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - S Odinga
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - C Borkowski
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - C Koop
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - J R Izbicki
- Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - M Wurlitzer
- Dept. of Clinical Chemistry, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - T Krech
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - W Wilczak
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - S Steurer
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - F Jacobsen
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - E-C Burandt
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - P Stahl
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - R Simon
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - G Sauter
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - H Schlüter
- Dept. of Clinical Chemistry, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| |
Collapse
|
6
|
Gustafsson OJR, Briggs MT, Condina MR, Winderbaum LJ, Pelzing M, McColl SR, Everest-Dass AV, Packer NH, Hoffmann P. MALDI imaging mass spectrometry of N-linked glycans on formalin-fixed paraffin-embedded murine kidney. Anal Bioanal Chem 2014; 407:2127-39. [PMID: 25434632 PMCID: PMC4357650 DOI: 10.1007/s00216-014-8293-7] [Citation(s) in RCA: 71] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2014] [Revised: 10/20/2014] [Accepted: 10/21/2014] [Indexed: 11/28/2022]
Abstract
Recent developments in spatial proteomics have paved the way for retrospective in situ mass spectrometry (MS) analyses of formalin-fixed paraffin-embedded clinical tissue samples. This type of analysis is commonly referred to as matrix-assisted laser desorption/ionization (MALDI) imaging. Recently, formalin-fixed paraffin-embedded MALDI imaging analyses were augmented to allow in situ analyses of tissue-specific N-glycosylation profiles. In the present study, we outline an improved automated sample preparation method for N-glycan MALDI imaging, which uses in situ PNGase F-mediated release and measurement of N-linked glycans from sections of formalin-fixed murine kidney. The sum of the presented data indicated that N-glycans can be cleaved from proteins within formalin-fixed tissue and characterized using three strategies: (i) extraction and composition analysis through on-target MALDI MS and liquid chromatography coupled to electrospray ionization ion trap MS; (ii) MALDI profiling, where N-glycans are released and measured from large droplet arrays in situ; and (iii) MALDI imaging, which maps the tissue specificity of N-glycans at a higher resolution. Thus, we present a complete, straightforward method that combines MALDI imaging and characterization of tissue-specific N-glycans and complements existing strategies. MALDI imaging MS of N-linked glycans released from formalin-fixed paraffin-embedded murine kidney sections. Ion intensity maps for (Hex)2(HexNAc)3(Deoxyhexose)3+(Man)3(GlcNAc)2 (m/z 2304.932, red), (Hex)6+(Man)3(GlcNAc)2 (m/z 1905.742, green) and (Hex)2(HexNAc)2+(Man)3(GlcNAc)2 (m/z 1663.756, blue) ![]()
Collapse
Affiliation(s)
- Ove J R Gustafsson
- Adelaide Proteomics Centre, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, 5005, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Steurer S, Borkowski C, Odinga S, Buchholz M, Koop C, Huland H, Becker M, Witt M, Trede D, Omidi M, Kraus O, Bahar AS, Seddiqi AS, Singer JM, Kwiatkowski M, Trusch M, Simon R, Wurlitzer M, Minner S, Schlomm T, Sauter G, Schlüter H. MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays. Int J Cancer 2013; 133:920-8. [DOI: 10.1002/ijc.28080] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2012] [Accepted: 01/21/2013] [Indexed: 12/27/2022]
Affiliation(s)
- Stefan Steurer
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Carina Borkowski
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Sinje Odinga
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Malte Buchholz
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Christina Koop
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Hartwig Huland
- Martini-Clinic at University Medical Center Hamburg-Eppendorf; Germany
| | | | | | - Dennis Trede
- Steinbeis Innovation Center SCiLS (Scientific Computing in Life Sciences); Bremen; Germany
| | - Maryam Omidi
- Institute of Clinical Chemistry; Mass Spectrometric Proteomics; University Medical Center Hamburg-Eppendorf; Germany
| | - Olga Kraus
- Institute of Clinical Chemistry; Mass Spectrometric Proteomics; University Medical Center Hamburg-Eppendorf; Germany
| | - Ahmad S. Bahar
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - A. Shoaib Seddiqi
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Julius M. Singer
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Marcel Kwiatkowski
- Institute of Clinical Chemistry; Mass Spectrometric Proteomics; University Medical Center Hamburg-Eppendorf; Germany
| | - Maria Trusch
- Institute of Organic Chemistry; Mass Spectrometry; University of Hamburg; Germany
| | - Ronald Simon
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Marcus Wurlitzer
- Institute of Clinical Chemistry; Mass Spectrometric Proteomics; University Medical Center Hamburg-Eppendorf; Germany
| | - Sarah Minner
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Thorsten Schlomm
- Martini-Clinic at University Medical Center Hamburg-Eppendorf; Germany
| | - Guido Sauter
- Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany
| | - Hartmut Schlüter
- Institute of Clinical Chemistry; Mass Spectrometric Proteomics; University Medical Center Hamburg-Eppendorf; Germany
| |
Collapse
|